Allergy and Immunology · Oklahoma City, OK
NPI
1700883808
Since 2005
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
750 NE 13th St
Oklahoma City, OK, 73104
Phone (405) 235-0040
Groups this clinician bills Medicare through
Medicare paid, 2024
$474K
30,500 services
Medicare patients, 2024
438
Average age 73
Drug cost, 2024
$1.5M
2,907 prescriptions
Company payments, 2025
$2,086
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dean A Atkinson was code 95165 (treatment - miscellaneous), 15,472 times for 290 patients. In total Dean A Atkinson billed 30,500 services in 23 codes, and Medicare paid $474K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 15,472 | 290 | $9.35 | $145K |
| 95004 Test - Miscellaneous | Office | 4,065 | 77 | $2.47 | $10K |
| 95117 Treatment - Miscellaneous | Office | 2,827 | 137 | $7.68 | $22K |
| 95024 Test - Miscellaneous | Office | 1,516 | 63 | $5.47 | $8,293 |
| 95115 Treatment - Miscellaneous | Office | 1,080 | 51 | $6.27 | $6,767 |
| 99214 Office E&M - Established | Office | 258 | 242 | $85.30 | $22K |
| 96372 Injection Administration | Office | 155 | 15 | $9.64 | $1,494 |
| 99204 Office E&M - New | Office | 94 | 94 | $110.06 | $10K |
| 94010 Pulmonary Function Testing | Office | 87 | 86 | $18.17 | $1,581 |
| 94060 Pulmonary Function Testing | Office | 37 | 36 | $25.14 | $930 |
By year: 2022 $378K for 27,834 services; 2023 $407K for 29,514 services; 2024 $474K for 30,500 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dean A Atkinson prescribed most often to Medicare patients was Montelukast Sodium, with 718 prescriptions and refills. In total Dean A Atkinson wrote 2,907 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 718 | 1,840 | 245 | $16K |
| Fluticasone Propionate Generic | 347 | 724 | 165 | $7,240 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 277 | 317 | 107 | $8,102 |
| Azelastine Hcl Generic | 232 | 452 | 119 | $9,393 |
| Epinephrine Generic | 159 | 169 | 138 | $30K |
| Ipratropium Bromide Generic | 149 | 239 | 71 | $7,179 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 103 | 149 | 35 | $18K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 86 | 106 | 22 | $67K |
| Omeprazole Generic | 81 | 178 | 23 | $1,917 |
| Advair Hfa Fluticasone Propion/Salmeterol | 66 | 98 | 18 | $31K |
| Breo Ellipta Fluticasone/Vilanterol | 60 | 82 | 13 | $33K |
| Spiriva Respimat Tiotropium Bromide | 58 | 83 | 17 | $42K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 51 | 81 | 24 | $7,867 |
| Ventolin Hfa Albuterol Sulfate | 43 | 48 | 25 | $2,489 |
| Symbicort Budesonide/Formoterol Fumarate | 41 | 67 | 19 | $14K |
Brand drugs: - claims; generic drugs: 2,048 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dean A Atkinson $2,086 ($2,086 in general payments such as food, travel and fees) from 17 companies. The largest payer was CSL Behring with $297.
| Company | Payments | Amount |
|---|---|---|
| CSL Behring CSL.AX | 14 | $297 |
| Regeneron Healthcare Solutions, Inc. REGN | 12 | $269 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $248 |
| Genzyme Corporation SNY | 12 | $235 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 5 | $210 |
| Pfizer Inc. PFE | 9 | $151 |
| Grifols USA, LLC | 2 | $145 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $145 |
| Genentech USA, Inc. ROG.SW | 1 | $120 |
| GlaxoSmithKline, LLC. GSK | 3 | $61.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.